Disc Medicine, Inc. 4

Chief Legal Officer Rahul Khara exercised 5,000 stock options at $14.69 and sold 5,000 Disc Medicine, Inc. common shares at $80.00 on August 6, 2026 under a Rule 10b5-1 plan.

On August 6, 2026, Disc Medicine, Inc. Chief Legal Officer Rahul Khara exercised 5,000 stock options at an exercise price of $14.69 per share, acquiring 5,000 shares of common stock, and on the same date sold 5,000 shares of common stock at $80.00 per share under a Rule 10b5-1 trading plan adopted on March 19, 2026. The option exercise, which was fully vested and carried no additional price beyond the stated exercise price, effectively converted derivative holdings into common stock, while the sale partially monetized his equity position at a substantial premium to the option strike. Following these transactions, Khara reported beneficial ownership of 49,804 shares of Disc Medicine common stock, including 151 shares acquired through the company’s 2021 Employee Stock Purchase Plan on July 31, 2026, maintaining a meaningful ongoing equity stake despite the sale.

Filing Facts

CIK

1816736

Ticker

IRON

Form

4

Source Type

fda

Accession

0001193125-26-340543

Alert Tier

6